Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IGF1R expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IGF1R overexpression + KRAS mutation (1)

IGF1R overexpression + KRAS mutation (1)

›

IGF1R expression	Thymoma	IGF1R expression	Thymoma	everolimus Resistant: C3 – Early Trials everolimus Resistant : C3	everolimus Resistant: C3 – Early Trials everolimus Resistant : C3
IGF1R expression	Thymic Carcinoma	IGF1R expression	Thymic Carcinoma	everolimus Resistant: C3 – Early Trials everolimus Resistant : C3	everolimus Resistant: C3 – Early Trials everolimus Resistant : C3
IGF1R expression	Ewing Sarcoma	IGF1R expression	Ewing Sarcoma	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D
IGF1R expression	Osteosarcoma	IGF1R expression	Osteosarcoma	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D
IGF1R expression	Soft Tissue Sarcoma	IGF1R expression	Soft Tissue Sarcoma	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D	IGF-1R inhibitor Sensitive: D – Preclinical IGF-1R inhibitor Sensitive : D